← Back to Search

Radiation Therapy

Yttrium-90 Radiation Segmentectomy for Liver Cancer (SBRT vs Y90 Trial)

N/A
Waitlist Available
Research Sponsored by Indiana University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 16 months for the first subject and 4 months for the second
Awards & highlights
No Placebo-Only Group

Summary

This trial will compare the effects of two different types of radiation therapy on early stage liver cancer.

Eligible Conditions
  • Liver Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~16 months for the first subject and 4 months for the second
This trial's timeline: 3 weeks for screening, Varies for treatment, and 16 months for the first subject and 4 months for the second for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Feasibility of Recruitment (Recruitment Rate)
Secondary study objectives
Disease-free Survival (DFS) Rates of RS and SBRT
Mean Change in Comprehensive Score for Financial Toxicity
Mean Change in Functional Assessment of Cancer Therapy- General (FACT-G) Score
+4 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: Yttrium-90 Radiation SegmentectomyActive Control1 Intervention
Group II: Stereotactic Body Radiation TherapyActive Control1 Intervention

Find a Location

Who is running the clinical trial?

Indiana UniversityLead Sponsor
1,040 Previous Clinical Trials
1,220,056 Total Patients Enrolled
2 Trials studying Liver Cancer
35 Patients Enrolled for Liver Cancer
~0 spots leftby Dec 2025